Logo image of CSH.DE

CENIT AG (CSH.DE) Stock Fundamental Analysis

FRA:CSH - Deutsche Boerse Ag - DE0005407100 - Common Stock - Currency: EUR

8.32  -0.22 (-2.58%)

Fundamental Rating

3

Overall CSH gets a fundamental rating of 3 out of 10. We evaluated CSH against 101 industry peers in the Software industry. CSH has a bad profitability rating. Also its financial health evaluation is rather negative. CSH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CSH has reported negative net income.
In the past year CSH had a positive cash flow from operations.
CSH had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CSH had a positive operating cash flow.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.91%, CSH is doing worse than 61.39% of the companies in the same industry.
Looking at the Return On Equity, with a value of -13.41%, CSH is doing worse than 65.35% of the companies in the same industry.
With a Return On Invested Capital value of 0.35%, CSH perfoms like the industry average, outperforming 46.53% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CSH is significantly below the industry average of 10.93%.
Industry RankSector Rank
ROA -2.91%
ROE -13.41%
ROIC 0.35%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

The Operating Margin of CSH (0.34%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CSH has declined.
The Gross Margin of CSH (59.34%) is worse than 60.40% of its industry peers.
CSH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.34%
PM (TTM) N/A
GM 59.34%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSH is destroying value.
Compared to 1 year ago, CSH has about the same amount of shares outstanding.
The number of shares outstanding for CSH remains at a similar level compared to 5 years ago.
The debt/assets ratio for CSH is higher compared to a year ago.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

CSH has an Altman-Z score of 1.94. This is not the best score and indicates that CSH is in the grey zone with still only limited risk for bankruptcy at the moment.
CSH has a Altman-Z score (1.94) which is in line with its industry peers.
CSH has a debt to FCF ratio of 6.47. This is a slightly negative value and a sign of low solvency as CSH would need 6.47 years to pay back of all of its debts.
CSH's Debt to FCF ratio of 6.47 is in line compared to the rest of the industry. CSH outperforms 57.43% of its industry peers.
CSH has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CSH (1.27) is worse than 78.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 6.47
Altman-Z 1.94
ROIC/WACC0.05
WACC6.85%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.27 indicates that CSH should not have too much problems paying its short term obligations.
CSH's Current ratio of 1.27 is in line compared to the rest of the industry. CSH outperforms 49.51% of its industry peers.
A Quick Ratio of 1.27 indicates that CSH should not have too much problems paying its short term obligations.
CSH has a Quick ratio (1.27) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

CSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -202.55%.
The Revenue has grown by 8.57% in the past year. This is quite good.
CSH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.84% yearly.
EPS 1Y (TTM)-202.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17693.75%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%1.91%

3.2 Future

Based on estimates for the next years, CSH will show a very strong growth in Earnings Per Share. The EPS will grow by 57.91% on average per year.
The Revenue is expected to grow by 4.43% on average over the next years.
EPS Next Y37.5%
EPS Next 2Y57.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.91%
Revenue Next 2Y7.35%
Revenue Next 3Y5.86%
Revenue Next 5Y4.43%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M 250M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSH. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 8.69 indicates a reasonable valuation of CSH.
CSH's Price/Forward Earnings ratio is rather cheap when compared to the industry. CSH is cheaper than 94.06% of the companies in the same industry.
CSH is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 8.69
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

CSH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CSH is cheaper than 90.10% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CSH indicates a rather cheap valuation: CSH is cheaper than 94.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.86
EV/EBITDA 8.01
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CSH's earnings are expected to grow with 57.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.91%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CSH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENIT AG

FRA:CSH (7/8/2025, 7:00:00 PM)

8.32

-0.22 (-2.58%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-01 2025-08-01
Inst Owners52.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap69.64M
Analysts88.89
Price Target16.44 (97.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.04
Dividend Growth(5Y)-41.82%
DP-6.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.03%
PT rev (3m)-3.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.69
P/S 0.33
P/FCF 8.86
P/OCF 7.36
P/B 1.94
P/tB N/A
EV/EBITDA 8.01
EPS(TTM)-0.57
EYN/A
EPS(NY)0.96
Fwd EY11.5%
FCF(TTM)0.94
FCFY11.29%
OCF(TTM)1.13
OCFY13.58%
SpS24.89
BVpS4.28
TBVpS-3.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -13.41%
ROCE 0.72%
ROIC 0.35%
ROICexc 0.48%
ROICexgc 4.96%
OM 0.34%
PM (TTM) N/A
GM 59.34%
FCFM 3.77%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
ROICexc(3y)4.78%
ROICexc(5y)6.49%
ROICexgc(3y)14.59%
ROICexgc(5y)14.62%
ROCE(3y)8.58%
ROCE(5y)8.95%
ROICexcg growth 3Y-6.55%
ROICexcg growth 5Y-5.33%
ROICexc growth 3Y-30.45%
ROICexc growth 5Y-21.57%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
F-Score4
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF 6.47
Debt/EBITDA 3.91
Cap/Depr 14.57%
Cap/Sales 0.77%
Interest Coverage 0.25
Cash Conversion 80.98%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 1.94
F-Score4
WACC6.85%
ROIC/WACC0.05
Cap/Depr(3y)19.26%
Cap/Depr(5y)16.81%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-202.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17693.75%
EPS Next Y37.5%
EPS Next 2Y57.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.57%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%1.91%
Revenue Next Year9.91%
Revenue Next 2Y7.35%
Revenue Next 3Y5.86%
Revenue Next 5Y4.43%
EBIT growth 1Y-93.22%
EBIT growth 3Y3.24%
EBIT growth 5Y-5.88%
EBIT Next Year139.79%
EBIT Next 3Y51.43%
EBIT Next 5Y30.03%
FCF growth 1Y6.46%
FCF growth 3Y5.1%
FCF growth 5Y-0.8%
OCF growth 1Y5.25%
OCF growth 3Y7.86%
OCF growth 5Y-2.42%